4//SEC Filing
Gall Matthew 4
Accession 0001209191-21-060297
CIK 0001808865other
Filed
Oct 11, 8:00 PM ET
Accepted
Oct 12, 8:02 PM ET
Size
7.4 KB
Accession
0001209191-21-060297
Insider Transaction Report
Form 4
Gall Matthew
Chief Financial Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-10-11−14,429→ 42,388 totalExercise: $6.16Exp: 2030-06-18→ Common Stock (14,429 underlying) - Exercise/Conversion
Common Stock
2021-10-11$6.16/sh+14,429$88,883→ 19,429 total
Footnotes (2)
- [F1]This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock.
- [F2]One-fourth of the shares subject to the stock option vested on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.
Documents
Issuer
iTeos Therapeutics, Inc.
CIK 0001808865
Entity typeother
Related Parties
1- filerCIK 0001816194
Filing Metadata
- Form type
- 4
- Filed
- Oct 11, 8:00 PM ET
- Accepted
- Oct 12, 8:02 PM ET
- Size
- 7.4 KB